|
| Pages | Title | Type | Autor | File |
|---|---|---|---|---|
| 1-172 | Status of gene therapy in 1997: molecular mechanisms, disease targets, and clinical applications | *N/A | Boulikas T | |
| 173-214 | The challenge of liposomes in gene therapy | *N/A | Martin F and Boulikas T | |
| 215-230 | Gene transfer to the nervous system using HSV vectors |
*N/A | Soares MK, Goins WH, Glorioso JC and Fink DJ | |
| 231-240 | The baculovirus vector system for gene delivery int hepatocytes |
*N/A | Hofmann C, Lehnert W, and Strauss M | |
| 241-252 | Delivery systems for the MDR1 gene | *N/A | Lee CG L, Vieira WD, Pastan I, and Gottesman MM | |
| 253-264 | Tumor killing using the HSV-tk suicide gene | *N/A | Ramesh R, Marrogi AJ, and Freeman SM | |
| 265-278 | Neurotrophic factor gene therapy for neurodegenerative diseases |
*N/A | Bohn MC and Choi-Lundberg DL | |
| 279-292 | Hemophilia A: current treatment and future gene therapy | *N/A | Connelly S and Kaleko M | |
| 293-300 | Gene therapy for haemophilia | *N/A | Hoeben RC | |
| 301-308 | Kallikrein gene therapy in hypertension, cardiovascular and renal diseases | *N/A | Chao J and Chao L | |
| 309-322 | Chemically defined, cell-free cancer vaccines: use of tumor antigen-derived peptides or polyepitope proteins for vaccination. |
*N/A | Buschle M, Schmidt W, Berger M, Schaffner G, Kurzbauer R, Killisch I, Tiedemann J-K, Trska B, Kirlappos H Mechtler K, Schilcher F, Gabler C, and Birnstiel ML |
|
| 323-332 | Somatic transgenesis by immunoglobulin gene | *N/A | Xiong S, Gerloni M and Zanetti M | |
| 333-344 | Applications of gene therapy in transplantation | *N/A | White-Scharf ME, Banerjee P, Sachs DH, and LeGuern C | |
| 345-364 | Myoblast transfer as a platform technology of gene therapy | *N/A | Law P, Goodwin T, Fang Q, Vastagh G, Jordan T, Jackson T, Kenny S, Duggirala V, Larkin C, Chase N, Phillips W, Williams G, Neel M, Krahn T, and Holcomb R |
|
| 365-380 | Constitutive activation of fibroblast growth factor receptors in human developmental syndromes |
*N/A | Webster MK and Donoghue DJ | |
| 381-398 | Genes involved in the control of tumor progression and their possible use for gene therapy |
*N/A | Georgiev GP, Kiselev SL and Lukanidin EM | |
| 399-406 | The Apoptin gene of chicken anemia virus in the induction of apoptosis in human tumorigenic cells and in gene therapy of cancer | *N/A | Noteborn MHM, Danen-van Oorschot AAAM and van der Eb AJ | |
| 407-418 | Tissue-specific triple ribozyme vectors for prostate cancer gene therapy |
*N/A | Voeks DJ, Clawson GA, and Norris JS | |
| 419-434 | A novel system for selection of intracellularly active ribozymes using the gene for dihydrofolate reductase (DHFR) as a selective marker in Escherichia coli | *N/A | Fujita S, Hamada M, Jigami Y, Kise H, and Taira K | |
| 435-350 | Comparison of the specificities and catalytic activities of conventional hammerhead ribozymes, Joyce's DNA enzymes, and novel dimeric minizymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA |
*N/A | Kuwabara T, Warashina M, Nakayama A, Hamada M, Amontov S, Takasuka Y, Komeiji Y, and Taira K | |
| 351-466 | Isolation and characterization of an RNA that binds with high affinity to Tat protein of HIV-1 from a completely random pool of RNA | *N/A | Yamamoto R, Murakami K, Taira K, and Kumar PKR | |
| 467-474 | Sequence-specific control of gene expression by antigene and clamp oligonucleotides |
*N/A | Hélène C, Garestier T, Giovannangeli C, and Sun J-S | |
| 475-482 | Physical approaches to the study of chromatin fibers | *N/A | van Holde K, Leuba SH and Zlatanova J | |
| 483-494 | Activation at a distance: involvement of nucleoprotein complexes that remodel chromatin | *N/A | Bresnick EH, Versaw WK, Lam LT, Forsberg EC, and Eisenman HC | |
| 495-508 | Dedicated sites of gene expression in the nuclei of mammalian cells |
*N/A | Iborra F, Pombo A and Jackson DA | |
| 509-529 | Nuclear matrix: application to diagnosis of cancer and role in transcription and modulation of chromatin structure | *N/A | Davie JR, Samuel S, Spencer V, Bajno L, Sun J-M, Chen HY, and Holth LT | |
| 529-542 | Structural organization and biological roles of the nuclear lamina | *N/A | Harel A, Goldberg M, Ulitzur N and Gruenbaum Y | |
| 543-550 | Analysis of mutant p53 for MAR-DNA binding: determining the dominant-oncogenic function of mutant p53 | *N/A | Will K and Deppert W | |
| 551-580 | Transcription-promoting genomic sites in mammalia: their elucidation and architectural principles |
*N/A | Bode J, Bartsch J, Boulikas T, Iber M, Mielke C, Schübeler D, Seibler J, and Benham C | |
| 581-590 | Synthetic concatemers as artificial MAR: importance of a particular configuration of short AT-tracts for protein recognition | *N/A | Tsutsui K | |
| 591-598 | Replicon map of the human dystrophin gene: asymmetric replicons and putative replication barriers |
*N/A | Verbovaia LV and Razin SV | |
| 599-608 | Initiation of DNA replication at the rat aldolase B locus.—An overlapping set of DNA elements regulates transcription and replication? | *N/A | Tsutsumi K-i and Zhao Y | |
| 609-612 | TARgeting the human genome to make gene isolation easy |
*N/A | Resnick MA, Kouprina N, and Larionov V | |
| 613-628 | Control of growth and proliferation by the retinoblastoma protein | *N/A | White RJ | |
| 629-640 | Transcriptional regulation of the H-ras1 proto-oncogene by DNA binding proteins: mechanisms and implications in human tumorigenesis | *N/A | Zachos G and Spandidos DA | |
| 641-648 | Periodicity of DNA bend sites in eukaryotic genomes | *N/A | Kiyama R | |
| 649-660 | DNA methyltransferase: a downstream effector of oncogenic programs; implications for therapy |
*N/A | Szyf M | |
| 661-680 | Correlation between DNA methylation and poly(ADP- ribosyl)ation processes |
*N/A | Zardo G, Marenzi S and Caiafa P | |
| 681-700 | Poly (ADP-ribosyl)ation as one of the molecular events that accompany mammalian spermatogenesis |
*N/A | Quesada P | |
| 701-706 | Membrane biogenesis: from mechanism to disease | *N/A | Haucke V | |
| 707-712 | Cdc25 protein phosphatase: regulation and its role in cancer | *N/A | Eckstein JW | |
| 713-740 | Nucleocytoplasmic trafficking: implications for the nuclear import of plasmid DNA during gene therapy |
*N/A | Boulikas T | |
| 741-748 | The ATP-driven protein translocation-motor of mitochondria |
*N/A | Satyanarayana C and Horst M |